Concise Prescribing Info
Dosage/Direction for Use
Essential HTN Initially 12.5 mg once daily for first 2 days. Maintenance: 25 mg once daily. If necessary, may increase at intervals of 2 wk to a total daily dose of 50 mg given once daily or in divided doses (bid). CHD Initially 12.5 mg bid for 1st 2 days. Maintenance: 25 mg bid. May increase at intervals of 2 wk to a total daily dose of 100 mg given in divided doses (bid). Elderly Max: 50 mg given in divided doses (bid). Treatment of symptomatic CHF Initially 3.125 mg bid for 2 wk. May increase at intervals of 2 wk to 6.25 mg bid, followed by 12.5 mg bid & thereafter 25 mg bid. Patient >85 kg Max: 50 mg bid, <85 kg Max: 25 mg bid. If carvedilol is discontinued for >2 wk, recommence at 3.125 mg bid & titrate dose accordingly. Left ventricular dysfunction following acute MI Initially 6.25 mg bid, may increase to 12.5 mg bid after 3-10 days & thereafter 25 mg bid. In case of low BP, heart rate or fluid retention, 3.125 mg bid may be used &/or the rate of uptitration may be slower.
Should be taken with food.
Class IV decompensated heart failure requiring IV inotropic support; asthma; COPD w/ bronchospastic component; liver dysfunction; 2nd- & 3rd-degree AV block; severe bradycardia (<50 bpm); cardiogenic shock; sick sinus syndrome; severe hypotension; pregnancy & lactation. Childn <18 yr.
Special Precautions
Markedly reduced heart performance; secondary or labile HTN; complete bundle branch block; peripheral vascular disease; impaired renal function; recent heart attack; tendency to hypotension; DM; phaeochromocytoma; psoriasis; Prinzmetal's or variant angina; concurrent therapy w/ digitalis, diuretics &/or ACE inhibitor. Patients undergoing general surgery. May obscure symptoms of thyrotoxicosis. May affect ability to drive or operate machinery. Gradual w/drawal over 1-2 wk.
Adverse Reactions
Dizziness, headache, fatigue, bradycardia, postural hypotension, hypotension, asthma/dyspnea, GI upset, skin reactions, changes in serum transaminases, thrombocytopenia, leucopenia, manifestation of latent DM, pain in the extremities.
Drug Interactions
Simultaneous therapy w/ other BP-lowering drugs, reserpine, guanethidine, methyldopa, clonidine, guanfacine, nifedipine, Ca antagonists of the verapamil or diltiazem type, antiarrhythmics, cardiac glycosides, barbiturates, phenothiazines, TCAs, vasodilators, & alcohol may cause an intensified BP &/or heart rate-lowering effects. May enhance effect of insulin or oral hypoglycemics & sign of hypoglycemia may be masked. Rifampicin reduces its BP-lowering effects. Digoxin, cyclosporin, amiodarone, fluoxetine, catecholamine-depleting agents, Ca channel blockers, antihypertensives, anesth, NSAID, β-agonist vasodilators.
MIMS Class
ATC Classification
C07AG02 - carvedilol ; Belongs to the class of alpha and beta blocking agents. Used in the treatment of cardiovascular diseases.
Dilatrend tab 12.5 mg
Dilatrend tab 25 mg
Dilatrend tab 6.25 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in